Call for proposals for African scientists: malaria drug development



 Medicines for Malaria Venture's 7th African call for proposals

To be eligible for consideration for funding as part of this call, MMV welcomes proposals only from endemic region African scientists focused in the following priority areas:

Compounds with confirmed activity on any antimalarial lifecycle stage

Novel molecules with confirmed activity (EC50 < 10uM) and a medicinal chemistry plan that tackles any known or anticipated liability. In line with MMV strategic goals, priority will be given to compounds with potential for optimization as drugs for chemoprevention with a human half-life >120h.

Assay development and screening

Assay development and screening to support discovery or development of novel antimalarials.

Computer-aided drug discovery

Use of computational approaches (cheminformatic and/or bioinformatic) to discover new molecules with predicted antimalarial activity or new antimalarial drug targets.

Please complete the African Letter of Interest template. Proposals involving a biological target should also include the target information template. See further instructions on how to complete the African Letter of Interest.


The proposals funded as part of this call will have a project start date of 1 January 2025.

Comments

Post a Comment

Popular posts from this blog

A global revolution in funding mental health care is coming

Image
The conversation about the mental health crisis is loud, but at a standstill. Stuck on repeat around the challenges of accessing existing treatments, the situation can appear increasingly hopeless.  I see another future — one far more positive and exciting. We are on the cusp of a revolution in mental health science. In five years’ time, the mental health treatment landscape will look radically different. We need funding to keep up with innovation. As mental health director at Wellcome, one of the largest nongovernmental funders of research in the world, I see scientific discoveries and technological advances sparking a wave of new therapies and solutions to transform people’s lives on a global scale.  The first new pharmacological approach for schizophrenia in more than 50 years, Cobenfy, has just been approved by the Food and Drug Administration. It works in a completely different way from any other currently used schizophrenia drugs and has the potential to change the lives...
Read more

Debunking The Most Common Myths On Mental Health

Image
Mental Health Awareness Month has been observed every May since 1949 with the aim to dispel stigmas and raise public awareness around it. If most people are unable to obtain the necessary care, it is because of misconceptions surrounding mental health issues. Stigma, or the shame and disgrace associated with requiring help for mental health issues, can be quite damaging. Considering the rising prevalence of anxiety, depression, and other related conditions, stigma forces people to needlessly suffer in silence. Nonetheless, it's critical that people recognise the significance of addressing mental health concerns.  Let us first dispel a few common misconceptions on mental health. Misconception 1 : Mental health issues are a sign of personal weakness. Mental health issues have nothing to do with a person’s character, personal weaknesses or poor upbringing. Mental health disorders, just like any other physical illnesses, occur due to several factors such as genetics, hormonal imbalanc...
Read more

Public health reminds islanders about flu vaccine

Image
Islanders who meet specific measures are being sent letters reminding them they fit the bill with the expectation of complimentary influenza inoculations. This incorporates pregnant ladies who can get to their immunization from maternity administrations. Likewise qualified are youngsters matured a half year to 18 years who are essential for a clinical gamble bunch. All kids are being offered a nasal influenza immunization, a splash elective that doesn't need an infusion. Subsequent stages This incorporates those matured two, three, and four who have not begun grade school and all younger students up to Year 11. From October the program will be reached out to individuals matured 65 and over and those matured 18 to 64 in a clinical gamble bunch. Likewise qualified will be those in long haul care offices, individuals who are the primary carer of an older individual or an individual with handicaps, close contacts of immunocompromised people, and bleeding edge medical services and socia...
Read more